Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Viatris Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Sep 2, 2024
Approval ID: 9dde0907246db675
Company: Viatris Limited
Type: Standard

Approval Details

Approval Id: 9dde0907246db675
Drug Cima Aemps Name: ILINPRU 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 89796
Holder Company Name: Viatris Limited
Marketing Company Name: Viatris Pharmaceuticals S.L.
Holder Company Detail Path: /organization/viatris-pharma-limited
Authorization Date: 2024-09-02
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 5 MG
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Viatris Limited
Company Detail Path: /organization/viatris-pharma-limited

Company Information

Pharmaceutical Company Name: VIATRIS PHARMA LIMITED
Country Name: Hong Kong, China
City Name: sha tin,country_hk
Address: Rm A7 8/F WAH WAI INDL BLDG

Active Ingredients

LINAGLIPTINA

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 2, 2024

Approval ID

9dde0907246db675

Type

Standard

Back to CIMA-AEMPS Approvals